AquaBounty Technologies (AQB) had the highest return in 2017 by a US stock in the Biotechnology Industry, returning 977,677.8%.
| ASSET | YEAR | % RETURN |
|---|---|---|
AquaBounty Technologies (AQB) | 2017 | 977,677.78% |
GT Biopharma (GTBP) | 2017 | 3,769.57% |
MDxHealth SA ADR (MDXH) | 2017 | 760% |
XOMA (XOMA) | 2017 | 747.62% |
AnaptysBio (ANAB) | 2017 | 529.5% |
Madrigal Pharmaceuticals (MDGL) | 2017 | 513.98% |
InMed Pharmaceuticals (INM) | 2017 | 506.61% |
Lexaria Bioscience (LEXX) | 2017 | 458.49% |
Palvella Therapeutics (PVLA) | 2017 | 447.1% |
Sangamo Therapeutics (SGMO) | 2017 | 429.03% |
Esperion Therapeutics (ESPR) | 2017 | 414.38% |
Fennec Pharmaceuticals (FENC) | 2017 | 402% |
Dynavax Technologies (DVAX) | 2017 | 367.5% |
EXACT Sciences (EXAS) | 2017 | 286.04% |
Assembly Biosciences (ASMB) | 2017 | 276.93% |
Catalyst Pharmaceuticals (CPRX) | 2017 | 275.96% |
Star Equity (STRR) | 2017 | 262.41% |
Avalo Therapeutics (AVTX) | 2017 | 259.55% |
argenx NV ADR (ARGX) | 2017 | 252.74% |
Uniqure (QURE) | 2017 | 247.34% |
Galectin Therapeutics (GALT) | 2017 | 244.33% |
Viking Therapeutics (VKTX) | 2017 | 238.33% |
Alnylam Pharmaceuticals (ALNY) | 2017 | 233.03% |
BeiGene (ONC) | 2017 | 219.01% |
Puma Biotechnology (PBYI) | 2017 | 216.32% |
